Abstract
11046Background: There are currently no FDA approved targeted therapies for sarcomas except GIST. Complicating this is the extreme diversity, heterogeneity, and rarity of these neoplasms. Few thera...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have